Patent · US Active

Anti-GPC3 antibodies and immunoconjugates

US9926377B2 · kind B2 · utility

2Cited by
0References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 21, 2015
Grant dateMar 27, 2018
Priority date
Expiry dateOct 31, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/4722
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-GPC3 antibodies and immunoconjugates and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.